Pathology of Lung Diseases: Obstructive vs. Restrictive & COPD

I. Overview of Pulmonary Function

Before diving into specific diseases, we must understand how lung pathologies are broadly categorized. Clinically, lung diseases are differentiated based on Pulmonary Function Tests (PFTs), specifically looking at FEV₁ (Forced Expiratory Volume in 1 second) and FVC (Forced Vital Capacity).

Obstructive Lung Diseases

Characterized by an increase in resistance to airflow due to diffuse airway narrowing or loss of elastic recoil. The patient can breathe air in, but struggles to push it out.

PFT Hallmark: The FEV₁ drops massively, while FVC drops only slightly or remains normal. Therefore, the FEV₁/FVC ratio is < 0.7 (70%).
Examples: COPD (Emphysema, Chronic Bronchitis), Asthma, Bronchiectasis.

Restrictive Lung Diseases

Characterized by reduced expansion of lung parenchyma and decreased Total Lung Capacity (TLC). The lungs are stiff or constrained.

PFT Hallmark: Both FEV₁ and FVC drop proportionately. Therefore, the FEV₁/FVC ratio remains normal (≥ 80%).
Examples: Chest wall disorders (severe obesity, kyphoscoliosis, polio) and Chronic Interstitial Fibrosis (pneumoconiosis).

II. Chronic Obstructive Pulmonary Disease (COPD)

Defined by the WHO as a common, preventable, and treatable disease characterized by persistent respiratory symptoms and progressive airflow limitation due to airway and/or alveolar abnormalities caused by noxious particles or gases.

Epidemiology: It is the 4th leading cause of death worldwide. 80% of COPD is directly attributable to cigarette smoking (35-50% of heavy smokers will develop COPD).
Risk Factors: Heavy smoking, female gender (women are more susceptible), African American descent, poor early-life lung development, occupational dust/chemicals, and genetic polymorphisms (e.g., α₁-antitrypsin deficiency).

The COPD Spectrum

COPD is an umbrella term encompassing two major clinicopathologic manifestations: Emphysema (alveolar wall destruction) and Chronic Bronchitis (airway inflammation and mucus). They almost always co-exist in the same patient because they share the same major trigger: cigarette smoking.

III. Emphysema (The "Pink Puffer")

Emphysema refers to the abnormal, permanent, and irreversible enlargement of the airspaces distal to the terminal bronchiole, accompanied by the destruction of their walls without obvious fibrosis.

1. Pathogenesis of Emphysema

How does smoke destroy the lung architecture? It involves four interconnected mechanisms:

Toxic Injury & Inflammation: Inhaled smoke damages the respiratory epithelium, triggering macrophages and neutrophils to flood the lung parenchyma.
Protease-Antiprotease Imbalance (Crucial Mechanism): Inflammatory cells (neutrophils) release Neutrophil Elastase, an enzyme that aggressively chews up lung elastic tissue. Normally, the liver produces α₁-Antitrypsin (α₁-AT), a protective "antiprotease" that neutralizes elastase. In emphysema, the sheer volume of elastase overwhelms α₁-AT. In patients with genetic α₁-AT deficiency, lung destruction happens rapidly even without heavy smoking.
Oxidative Stress: Free radicals in tobacco smoke (and from inflammatory cells) directly damage endothelial tissues and actually inactivate α₁-AT, worsening the imbalance.
Infection: Bacterial/viral infections exacerbate the existing inflammatory state.

2. Anatomic Classifications of Emphysema

Type	Pathology & Location	Clinical Association
Centriacinar (Centrilobular)	Involves the central/proximal acini (respiratory bronchioles). Distal alveoli are spared. Usually more pronounced in the Upper Lobes (apical segments).	Most common form (>95%). Seen predominantly in heavy smokers.
Panacinar (Panlobular)	Uniform enlargement of the entire acinus from bronchiole to blind alveoli. Usually most severe at the Bases (Lower Lobes).	Associated with α₁-Antitrypsin deficiency (exacerbated by smoking).
Paraseptal (Distal Acinar)	Proximal acinus is normal; distal part is involved. Occurs adjacent to the pleura or along connective tissue septa, forming large cysts/bullae.	Underlies many cases of Spontaneous Pneumothorax (collapsed lung) in young adults.
Irregular	Acinus is irregularly involved. Airspace enlargement is associated with distinct scarring.	Usually asymptomatic; incidental autopsy finding near old lung scars.

3. Morphology of Emphysema

Gross: Voluminous, over-inflated lungs that often overlap the heart anteriorly. Apical blebs or massive bullae may be present.
Microscopic: Abnormally large alveoli separated by paper-thin septa.
- The Pores of Kohn become so large that septa appear to be floating blindly in the airspace with club-shaped ends.
- Loss of Elastic Recoil: Because alveolar walls are destroyed, the radial traction that normally holds small airways open is lost. Airways collapse during expiration, trapping air.
- Capillary Loss: Destruction of alveolar walls means a massive decrease in the pulmonary capillary bed area, leading to pulmonary hypertension.

IV. Chronic Bronchitis (The "Blue Bloater")

Unlike emphysema (which is defined anatomically), chronic bronchitis is defined clinically as a persistent cough with sputum production for at least 3 months in at least 2 consecutive years, in the absence of any other identifiable cause.

1. Pathogenesis

The primary initiating factor is chronic irritation from inhaled substances (tobacco smoke, silica dust, cotton).

Mucus Hypersecretion: The earliest feature. Irritants cause massive hypertrophy (enlargement) of the submucosal mucus glands in the trachea and large bronchi.
Acquired CFTR Dysfunction: Smoking damages the Cystic Fibrosis Transmembrane Conductance Regulator channel. This causes the secretion of abnormal, dehydrated, excessively thick mucus.
Inflammation & Fibrosis: Chronic neutrophil and macrophage infiltration leads to fibrosis of small airways (bronchiolitis obliterans), physically obstructing airflow.
Infection: Secondary bacterial colonization maintains inflammation and causes acute exacerbations.

2. Morphology & The Reid Index

Gross: Hyperemia (redness), swelling, and edema of mucous membranes. Airways are choked with heavy mucopurulent casts.
Microscopic: Chronic inflammation, goblet cell hyperplasia, squamous metaplasia (changing from ciliated columnar to squamous epithelium due to stress), and peribronchial fibrosis.

Diagnostic Metric: The Reid Index

The Reid Index is a histological measurement to quantify Chronic Bronchitis. It is the ratio of the thickness of the submucosal mucus gland layer to the thickness of the wall between the epithelium and the cartilage.

Normal Reid Index: < 0.4
Chronic Bronchitis: > 0.4 (often severely increased in proportion to disease severity).

V. Clinical Comparison: Emphysema vs. Chronic Bronchitis

Patients rarely have pure emphysema or pure bronchitis, but classic phenotypes exist:

Feature	Predominant Emphysema ("Pink Puffer")	Predominant Bronchitis ("Blue Bloater")
Age of Onset	50 – 75 years	40 – 45 years
Dyspnea (Shortness of Breath)	Severe; occurs early in the disease	Mild; occurs late in the disease
Cough	Late onset; scanty, clear sputum	Early onset; copious purulent sputum
Infections	Occasional	Very Common
Cor Pulmonale (Right Heart Failure)	Uncommon until end-stage disease	Common (due to severe hypoxia & pulmonary hypertension)
Chest Radiograph	Hyperinflation, flat diaphragm, small heart	Prominent vessels, large heart size